Home>
US Stocks>
Biorestorative Therapies

Biorestorative Therapies share price today

(BRTX)

Biorestorative Therapies share price is $1.54 & ₹131.20 as on 25 Dec 2024, 2.30 'hrs' IST

$1.54

▲

0.02

(1.32%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Biorestorative Therapies share price in Dollar and Rupees. Guide to invest in Biorestorative Therapies from India. Also see the sentimental analysis on Indian investors investing in Biorestorative Therapies. Get details on the Indian mutual funds that are investing in Biorestorative Therapies. Get Analyst recommendations and forecasts along with all the Biorestorative Therapies's financials.

Biorestorative Therapies share price movements

Today's Low: $1.52
Today's High: $1.57
$1.54
1.3%
Downside
Day's Volatility :3.0%
Upside
1.72%
52 Weeks Low: $1.03
52 Weeks High: $3.67
$1.54
33.12%
Downside
52 Weeks Volatility :71.93%
Upside
58.04%

Biorestorative Therapies Returns

Period	Biorestorative Therapies Inc	Index (Russel 2000)
3 Months	-9.42%	0.0%
6 Months	-15.85%	0.0%
1 Year	-15.85%	0.0%
3 Years	-66.88%	-21.1%

Biorestorative Therapies Key Statistics

in dollars & INR

Previous Close	$1.52
Open	$1.51
Today's High	$1.567
Today's Low	$1.52
Market Capitalization	$10.7M
Today's Volume	$14.8K
52 Week High	$3.6699
52 Week Low	$1.03
Revenue TTM	$377.0K
EBITDA	$-11.9M
Earnings Per Share (EPS)	$-2.38
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-17.12%

How to invest in Biorestorative Therapies from India?

It is very easy for Indian residents to invest directly in Biorestorative Therapies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biorestorative Therapies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biorestorative Therapies or BRTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biorestorative Therapies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biorestorative Therapies shares which would translate to 0.553 fractional shares of Biorestorative Therapies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biorestorative Therapies, in just a few clicks!

Returns in Biorestorative Therapies for Indian investors in Rupees

Investment Value

₹1,00,000

Biorestorative Therapies investment value today

Current value as on today

₹86,579

Returns

₹13,421

(-13.42%)

Returns from Biorestorative Therapies Stock

₹15,847 (-15.85%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Biorestorative Therapies

67%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Biorestorative Therapies on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 67% more investors are searching Biorestorative Therapies in the last 30 days versus the previous period.

Global Institutional Holdings in Biorestorative Therapies

Geode Capital Management, LLC
0.81%
StoneX Group Inc
0.72%
Wealth Alliance, LLC
0.58%
Vanguard Group Inc
0.30%
State Street Corp
0.30%
Renaissance Technologies Corp
0.29%

Analyst Recommendation on Biorestorative Therapies

Buy

87%Buy

12%Hold

0%Sell

Based on 8 Wall street analysts offering stock ratings for Biorestorative Therapies(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Biorestorative Therapies

What analysts predicted

Upside of 744.16%

Current:

$1.54

Target:

$13.00

Insights on Biorestorative Therapies

Price Movement
In the last 7 days, BRTX stock has moved up by 9.2%
Increasing Revenue
Revenue is up for the last 4 quarters, 30.7K → 233.6K (in $), with an average increase of 45.0% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -4.02M → -1.09M (in $), with an average increase of 269.1% per quarter
BRTX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.3% return, outperforming this stock by 39.2%
BRTX vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 93.1%
Price to Sales
ForBRTX every $1 of sales, investors are willing to pay $28.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Biorestorative Therapies Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$111.0K	↑ 37.04%
Net Income	$-12.5M	↑ 32.54%
Net Profit Margin	-11.3K%	↑ 382.77%

	FY19	Y/Y Change
Revenue	$130.0K	↑ 17.12%
Net Income	$-14.6M	↑ 17.02%
Net Profit Margin	-11.3K%	↑ 9.69%

	FY20	Y/Y Change
Revenue	$77.0K	↓ 40.77%
Net Income	$-12.3M	↓ 16.34%
Net Profit Margin	-15.9K%	↓ 4647.56%

	FY21	Y/Y Change
Revenue	$46.0K	↓ 40.26%
Net Income	$-29.9M	↑ 144.3%
Net Profit Margin	-65.1K%	↓ 49168.75%

	FY22	Y/Y Change
Revenue	$119.8K	↑ 160.43%
Net Income	$-18.0M	↓ 39.83%
Net Profit Margin	-15.0K%	↑ 50045.93%

	FY23	Y/Y Change
Revenue	$145.8K	↑ 21.7%
Net Income	$-10.4M	↓ 42.17%
Net Profit Margin	-7.1K%	↑ 7892.79%

	Q1 FY23	Q/Q Change
Revenue	$31.3K	↑ 745.95%
Net Income	$-5.6M	↑ 46.71%
Net Profit Margin	-17.9K%	↑ 85386.42%

	Q2 FY23	Q/Q Change
Revenue	$64.5K	↑ 106.07%
Net Income	$-3.0M	↓ 46.85%
Net Profit Margin	-4.6K%	↑ 13294.52%

	Q3 FY23	Q/Q Change
Revenue	$30.7K	↓ 52.4%
Net Income	$-83.3K	↓ 97.2%
Net Profit Margin	-271.44%	↑ 4349.57%

	Q1 FY24	Q/Q Change
Revenue	$35.0K	↑ 14.01%
Net Income	$-2.2M	↑ 2567.92%
Net Profit Margin	-6.4K%	↓ 6080.72%

	Q2 FY24	Q/Q Change
Revenue	$89.1K	↑ 154.57%
Net Income	$-4.0M	↑ 81.2%
Net Profit Margin	-4.5K%	↑ 1830.77%

	Q3 FY24	Q/Q Change
Revenue	$233.6K	↑ 162.18%
Net Income	$-1.1M	↓ 72.91%
Net Profit Margin	-467.22%	↑ 4054.17%

	FY18	Y/Y Change
Profit	$111.0K	↑ 37.04%

	FY20	Y/Y Change
Profit	$77.0K	-

	FY21	Y/Y Change
Profit	$-159.2K	↓ 306.76%

	FY22	Y/Y Change
Profit	$-160.9K	↑ 1.04%

	FY23	Y/Y Change
Profit	$-19.9K	↓ 87.61%

	Q1 FY23	Q/Q Change
Profit	$-37.1K	↓ 63.37%

	Q2 FY23	Q/Q Change
Profit	$-6.0K	↓ 83.71%

	Q3 FY23	Q/Q Change
Profit	$-11.4K	↑ 89.58%

	Q1 FY24	Q/Q Change
Profit	$-7.7K	↓ 32.61%

	Q2 FY24	Q/Q Change
Profit	$82.6K	↓ 1171.05%

	Q3 FY24	Q/Q Change
Profit	$215.4K	↑ 160.69%

	FY18	Y/Y Change
Operating Cash Flow	$-5.1M	↑ 32.46%
Investing Cash Flow	$-12.9K	↑ 255.79%
Financing Cash Flow	$4.8M	↑ 11.83%

	FY19	Y/Y Change
Operating Cash Flow	$-6.9M	↑ 35.54%
Investing Cash Flow	$-35.6K	↑ 176.87%
Financing Cash Flow	$6.8M	↑ 42.97%

	FY20	Y/Y Change
Operating Cash Flow	$-2.0M	↓ 71.61%
Investing Cash Flow	$-35.6K	↑ 0.0%
Financing Cash Flow	$5.0M	↓ 26.49%

	FY21	Y/Y Change
Operating Cash Flow	$-3.3M	↑ 69.52%
Investing Cash Flow	$-30.7K	↓ 13.96%
Financing Cash Flow	$21.3M	↑ 324.15%

	FY22	Y/Y Change
Operating Cash Flow	$-5.9M	↑ 76.3%
Investing Cash Flow	$-13.5M	↑ 43866.95%
Financing Cash Flow	$21.1M	↓ 1.17%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-2.3M	↑ 49.28%
Investing Cash Flow	$665.8K	↓ 120.04%
Financing Cash Flow	$411.7K	↑ 0.0%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.1M	↓ 51.88%
Investing Cash Flow	$665.8K	↑ 0.0%
Financing Cash Flow	$411.7K	↑ 0.0%

Biorestorative Therapies Technicals Summary

Sell

Neutral

Buy

Biorestorative Therapies is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Biorestorative Therapies Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Biorestorative Therapies Inc	1.99%	-15.85%	-15.85%	-66.88%	-78.06%
Regeneron Pharmaceuticals, Inc.	-4.68%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-5.49%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.08%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-11.59%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Biorestorative Therapies Inc	NA	NA	0.0	0.0	-0.17	-0.53	NA	1.44
Regeneron Pharmaceuticals, Inc.	17.7	17.7	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Biorestorative Therapies Inc	Buy	$10.7M	-78.06%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.6B	91.19%	17.7	33.61%
Biontech Se	Buy	$27.2B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.2B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$104.4B	86.41%	32.84	-4.51%

About Biorestorative Therapies

biorestorative therapies, inc. (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. our two core programs, as described below, relate to the treatment of disc/spine disease and metabolic disorders: • disc/spine program (brtxdisc™): our lead cell therapy candidate, brtx-100, is a product formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. we intend that the product will be used for the non-surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. the brtx-100 production process involves collecting a patient’s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. in an outpatient procedure, brtx-100 is to be injected by a physician into the patient’s damaged disc. the treatment is intended for patients whose pain has not been alleviated by non-invas

Organization	Biorestorative Therapies
Employees	11
CEO	Mr. Lance Alstodt
Industry	Biotechnology

Management People of Biorestorative Therapies

Name	Title
Mr. Lance Alstodt	Chairman of the Board, President & CEO
Mr. Robert Eugene Kristal	Chief Financial Officer
Mr. Francisco J. Silva	Chief Scientist, VP of Research & Development, Secretary and Director
Stephen Kilmer	Investor Relations Officer
Mr. Robert Paccasassi	Vice President of Quality Assurance & Regulatory Compliance
Dr. Wayne J. Olan M.D.	Clinical Director of Regenerative Disc & Spine Program and Member of Scientific Advisory Board

Important FAQs about investing in Biorestorative Therapies from India :

What is Biorestorative Therapies share price today?

Biorestorative Therapies share price today stands at $1.54, Open: $1.51 ; Previous Close: $1.52 ; High: $1.57 ; Low: $1.52 ; 52 Week High: $3.67 ; 52 Week Low: $1.03. The stock opens at $1.51, after a previous close of $1.52. The stock reached a daily high of $1.57 and a low of $1.52, with a 52-week high of $3.67 and a 52-week low of $1.03.

Can Indians buy Biorestorative Therapies shares?

Yes, Indians can invest in the Biorestorative Therapies (BRTX) from India.

With INDmoney, you can buy Biorestorative Therapies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Biorestorative Therapies at zero transaction cost.

How can I buy Biorestorative Therapies shares from India?

It is very easy to buy Biorestorative Therapies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biorestorative Therapies be purchased?

Yes, you can buy fractional shares of Biorestorative Therapies with INDmoney app.

What are the documents required to start investing in Biorestorative Therapies stocks?

To start investing in Biorestorative Therapies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.